NEPHROS, INC. (NEPH) Free cash flow
- Free cash flow · 12 months (USD): Value (m); Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | (m) | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | (m) | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $-706.00K | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | -0.41× | Operating cash flow / net income. Period ending 2026-06-30. $-706.00K ÷ $1.74M ≈ -0.41× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | -706.00K USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations |
| Capital spending | (m) | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | (m) | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 20.72M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | 1.74M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $-706.00K | (m) | (m) | $20.72M | (m) | $1.74M | (m) | (m) | (m) | -0.41× |
| 2026-03-31 | (m) | (m) | $-393.00K | (m) | (m) | $19.12M | (m) | $776.00K | (m) | (m) | (m) | -0.51× |
| 2025-12-31 | (m) | (m) | $1.65M | (m) | (m) | $18.79M | (m) | $1.19M | (m) | (m) | (m) | 1.38× |
| 2025-09-30 | (m) | (m) | $2.72M | (m) | (m) | $17.93M | (m) | $1.48M | (m) | (m) | (m) | 1.84× |
| 2025-06-30 | (m) | (m) | $2.00M | (m) | (m) | $16.68M | (m) | $1.33M | (m) | (m) | (m) | 1.50× |
| 2025-03-31 | (m) | (m) | $502.00K | (m) | (m) | $15.52M | (m) | $801.00K | (m) | (m) | (m) | 0.63× |
| 2024-12-31 | $-547.00K | (m) | $-492.00K | $55.00K | (m) | $14.16M | (m) | $74.00K | (m) | (m) | -3.86% | -6.65× |
| 2024-09-30 | (m) | (m) | $-2.06M | (m) | (m) | $13.55M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | $-875.00K | (m) | (m) | $13.77M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | $-148.00K | (m) | (m) | $14.06M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $752.00K | (m) | $827.00K | $75.00K | (m) | $14.24M | (m) | (m) | (m) | (m) | 5.28% | (m) |
| 2023-09-30 | (m) | (m) | $869.00K | (m) | (m) | $13.54M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | $137.00K | (m) | (m) | $12.21M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | $-1.16M | (m) | (m) | $11.51M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $-3.37M | (m) | $-3.23M | $137.00K | (m) | $9.97M | (m) | (m) | (m) | (m) | -33.79% | (m) |
| 2022-09-30 | $-3.51M | (m) | $-3.37M | $137.00K | (m) | $10.32M | (m) | $-7.33M | (m) | (m) | -34.03% | 0.46× |
| 2022-06-30 | $-4.26M | (m) | $-4.11M | $150.00K | (m) | $10.47M | (m) | $-5.31M | (m) | (m) | -40.71% | 0.78× |
| 2022-03-31 | $-3.21M | (m) | $-3.16M | $47.00K | (m) | $9.86M | (m) | $-5.30M | (m) | (m) | -32.53% | 0.60× |
| 2021-12-31 | $-1.45M | (m) | $-1.42M | $36.00K | (m) | $10.40M | (m) | $-3.87M | (m) | (m) | -13.97% | 0.37× |
| 2021-09-30 | $-2.64M | (m) | $-2.61M | $36.00K | (m) | $9.97M | (m) | $-3.58M | (m) | (m) | -26.51% | 0.73× |
| 2021-06-30 | $-3.55M | (m) | $-3.52M | $36.00K | (m) | $9.46M | (m) | $-3.43M | (m) | (m) | -37.55% | 1.02× |
| 2021-03-31 | (m) | (m) | $-5.12M | (m) | (m) | $8.77M | (m) | $-3.96M | (m) | (m) | (m) | 1.29× |
| 2020-12-31 | $-7.14M | (m) | $-6.90M | $239.00K | (m) | $8.56M | (m) | $-4.53M | (m) | (m) | -83.42% | 1.53× |
| 2020-09-30 | $-5.25M | (m) | $-5.01M | $239.00K | (m) | $9.39M | (m) | $-4.15M | (m) | (m) | -55.94% | 1.21× |
| 2020-06-30 | (m) | (m) | $-3.81M | (m) | (m) | $10.36M | (m) | $-3.88M | (m) | (m) | (m) | 0.98× |
| 2020-03-31 | (m) | (m) | $-3.42M | (m) | (m) | $11.09M | (m) | $-3.17M | (m) | (m) | (m) | 1.08× |
| 2019-12-31 | $-2.29M | (m) | $-2.28M | $14.00K | (m) | $10.33M | (m) | $-3.42M | (m) | (m) | -22.16% | 0.67× |
| 2019-09-30 | (m) | (m) | $-3.17M | (m) | (m) | $8.79M | (m) | $-3.94M | (m) | (m) | (m) | 0.80× |
| 2019-06-30 | (m) | (m) | $-3.68M | (m) | (m) | $7.41M | (m) | $-3.70M | (m) | (m) | (m) | 0.99× |
| 2019-03-31 | (m) | (m) | $-3.69M | (m) | (m) | $6.47M | (m) | $-3.38M | (m) | (m) | (m) | 1.09× |
| 2018-12-31 | (m) | (m) | $-3.66M | (m) | (m) | $5.69M | (m) | $-3.40M | (m) | (m) | (m) | 1.08× |
| 2018-09-30 | (m) | (m) | $-1.34M | (m) | (m) | $5.38M | (m) | $-1.39M | (m) | (m) | (m) | 0.97× |
| 2018-06-30 | (m) | (m) | $-931.00K | (m) | (m) | $4.57M | (m) | $-1.45M | (m) | (m) | (m) | 0.64× |
| 2018-03-31 | (m) | (m) | $-87.00K | (m) | (m) | $4.06M | (m) | $-1.56M | (m) | (m) | (m) | 0.06× |
| 2017-12-31 | (m) | (m) | $-77.00K | (m) | (m) | $3.81M | (m) | $-809.00K | (m) | (m) | (m) | 0.10× |
| 2017-09-30 | (m) | (m) | $-2.40M | (m) | (m) | $3.25M | (m) | $-2.75M | (m) | (m) | (m) | 0.87× |
| 2017-06-30 | (m) | (m) | $-2.48M | (m) | (m) | $2.81M | (m) | $-2.83M | (m) | (m) | (m) | 0.88× |
| 2016-12-31 | $-2.16M | (m) | $-2.11M | $45.00K | (m) | $2.32M | (m) | $-3.03M | (m) | (m) | -92.97% | 0.70× |
| 2016-09-30 | (m) | (m) | $-2.82M | (m) | (m) | $2.09M | (m) | $-3.31M | (m) | (m) | (m) | 0.85× |
| 2016-06-30 | (m) | (m) | $-3.16M | (m) | (m) | $1.93M | (m) | $-3.19M | (m) | (m) | (m) | 0.99× |
| 2016-03-31 | (m) | (m) | $-3.42M | (m) | (m) | $1.99M | (m) | $-4.17M | (m) | (m) | (m) | 0.82× |
| 2015-12-31 | $-3.83M | (m) | $-3.81M | $13.00K | (m) | $1.94M | (m) | $-3.09M | (m) | (m) | -196.91% | 1.24× |
| 2013-12-31 | $-3.58M | (m) | $-3.58M | $0.00 | (m) | $1.74M | (m) | $-3.70M | (m) | (m) | -205.92% | 0.97× |
| 2012-12-31 | $-1.55M | (m) | $-1.55M | $8.00K | (m) | $1.81M | (m) | $-3.26M | (m) | (m) | -86.05% | 0.47× |
| 2012-09-30 | (m) | (m) | $-1.71M | (m) | (m) | $1.93M | (m) | $-2.80M | (m) | (m) | (m) | 0.61× |
| 2012-06-30 | (m) | (m) | $-580.00K | (m) | (m) | $1.73M | (m) | $-2.36M | (m) | (m) | (m) | 0.25× |
| 2010-12-31 | $-1.32M | (m) | $-1.29M | $30.00K | (m) | $2.94M | (m) | $-1.93M | (m) | (m) | -45.00% | 0.67× |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |